EP0174980A4 - Utilisation d'un composé du manganèse dans la fabrication d'un médicament pour le traitement de l'hypothyroidisme. - Google Patents

Utilisation d'un composé du manganèse dans la fabrication d'un médicament pour le traitement de l'hypothyroidisme.

Info

Publication number
EP0174980A4
EP0174980A4 EP19850901681 EP85901681A EP0174980A4 EP 0174980 A4 EP0174980 A4 EP 0174980A4 EP 19850901681 EP19850901681 EP 19850901681 EP 85901681 A EP85901681 A EP 85901681A EP 0174980 A4 EP0174980 A4 EP 0174980A4
Authority
EP
European Patent Office
Prior art keywords
hypothyroidism
medicament
preparation
treatment
manganese compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19850901681
Other languages
German (de)
English (en)
Other versions
EP0174980A1 (fr
Inventor
Vernon Erk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0174980A1 publication Critical patent/EP0174980A1/fr
Publication of EP0174980A4 publication Critical patent/EP0174980A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/32Manganese; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP19850901681 1984-03-01 1985-03-01 Utilisation d'un composé du manganèse dans la fabrication d'un médicament pour le traitement de l'hypothyroidisme. Withdrawn EP0174980A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58528984A 1984-03-01 1984-03-01
US585289 1984-03-01

Publications (2)

Publication Number Publication Date
EP0174980A1 EP0174980A1 (fr) 1986-03-26
EP0174980A4 true EP0174980A4 (fr) 1987-10-08

Family

ID=24340810

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19850901681 Withdrawn EP0174980A4 (fr) 1984-03-01 1985-03-01 Utilisation d'un composé du manganèse dans la fabrication d'un médicament pour le traitement de l'hypothyroidisme.

Country Status (4)

Country Link
EP (1) EP0174980A4 (fr)
JP (1) JPS61501570A (fr)
AU (1) AU597561B2 (fr)
WO (1) WO1985003867A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4654213A (en) * 1985-09-11 1987-03-31 Cheesebrough-Pond's Inc. Novel anti-microbial systems containing the magnesium sulfate adduct of 2,2'-dithiobis-pyridine-1,1'-dioxide and a water soluble zinc salt

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2507354A1 (de) * 1975-02-20 1976-09-09 Verla Pharm Pharmazeutische zubereitung
US4337245A (en) * 1980-07-21 1982-06-29 Baisden C Robert Nutrient compound
HU187467B (en) * 1981-11-02 1986-01-28 Vetoemagtermeltetoe Es Ertekesitoe Vallalat,Hu Method for producing preparation suitable for preventing health deterioration of alimentary origin promoting the utilization of fodder of animals
US4752479A (en) * 1986-05-27 1988-06-21 Ciba-Geigy Corporaton Multi vitamin and mineral dietary supplement with controlled release bioavailable iron

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8503867A1 *

Also Published As

Publication number Publication date
EP0174980A1 (fr) 1986-03-26
AU597561B2 (en) 1990-06-07
JPS61501570A (ja) 1986-07-31
WO1985003867A1 (fr) 1985-09-12
AU4110885A (en) 1985-09-24

Similar Documents

Publication Publication Date Title
EG18338A (en) New pharmacologycally active compounds
PH22614A (en) 9-amino-1,2,3,4-tetrahydroacridin-1-alpha and related compounds and their use as medicament
GR1002252B (en) A novel therapeutic active compound and preparation method therefore.
ZA848375B (en) Medicament formulation
EP0183527A3 (en) Absorbable calcitonin medicament
GB8414044D0 (en) Administering powdered substances
AR243183A1 (es) Derivados de acido acrilico, procedimiento para su preparacion, composicion que los contiene y compuestos intermedio utilizado en dicho procedimiento.
IL75240A0 (en) 1-heteroaryl-4-aryl-pyrazolin-5-ones,their preparation and their use as microbicides
ZA859065B (en) 1-heteroaryl-4-aryl-pyrazolin-5-ones for use as medicaments
PH25605A (en) 16-dehydro-vitamin d3-derivatives, medicament contatining said compounds
USD278661S (en) Children's tooth brush
ZA838802B (en) A water-dispersible polyester,its preparation,and its use as a hydrophiling agent
EP0224596A4 (fr) Utilisation de dibenzocyclooctadiene-lignanes extraits de Schisandrae Fructus pour la fabrication d'un médicament pour le traitement de la défaillance hépatique.
EP0174980A4 (fr) Utilisation d'un composé du manganèse dans la fabrication d'un médicament pour le traitement de l'hypothyroidisme.
GB8521395D0 (en) Medicament
GB2124485B (en) Penetrating topical medicament
IL68187A0 (en) 5-trichloromethylisoxazole,its preparation and its use for the preparation of 5-isoxazolecarboxylic acid
IL80185A0 (en) Phenoxy compounds,their preparation and their use as microbicides
AU560343B2 (en) Physiologically active pterocarpan compounds
EP0190219A4 (fr) Composition de traitement des haemorrhoides.
GR862804B (en) Preventing inadvertent downthrottling of the operative engine in a ..
GB8620716D0 (en) Medicament
AU589684C (en) Arylmethylazoles and their salts, processes for their preparation, agents which contain these compounds, and their use.
AU589684B2 (en) Arylmethylazoles and their salts, processes for their preparation, agents which contain these compounds, and their use.
IL79771A0 (en) Aryldioxolane-and aryldioxane-pyrimidines,their preparation and their use as microbicides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB LI LU NL SE

17P Request for examination filed

Effective date: 19860312

RBV Designated contracting states (corrected)

Designated state(s): DE FR GB

A4 Supplementary search report drawn up and despatched

Effective date: 19871008

17Q First examination report despatched

Effective date: 19891030

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19940104